Amanda C. Bryant-Friedrich | |
---|---|
Born | |
Alma mater | North Carolina Central University (BS) Duke University (MS) Heidelberg University (PhD) |
Awards | Fellow of the: American Association for the Advancement of Science (2019) American Chemical Society (2018) |
Scientific career | |
Institutions | University of Toledo Oakland University Wayne State University |
Thesis | Synthesen und Eigenschaften von alkinylsubstituierten 1 (1997) |
Amanda Cordelia Bryant-Friedrich is the dean of the graduate school and a professor in the college of pharmacy and health sciences at Wayne State University. She was awarded the 2014 American Chemical Society Stanley C. Israel Regional Award for Advancing Diversity in the Chemical Sciences and is a Fellow of the American Association for the Advancement of Science and the American Chemical Society. Her research considers modified nucleic acids and biomarkers of disease.
Byrant-Friedrich was born in Enfield, North Carolina. [1] She is the daughter of a farmer and, alongside her education in the Halifax County School system, worked on the family farm. She graduated high school as Valedictorian and moved on to attend university. [1] Whilst she was offered a full academic scholarship at Duke University, she was encouraged by her guidance counsellor to attend North Carolina Central University. She eventually earned her bachelor's degree in chemistry at North Carolina Central University, where she worked in the laboratory of John Meyers. [1] She became increasingly interested in scientific research and spent a summer holiday as an intern at Dow Chemical Company. [1] She eventually graduated magna cum laude with a bachelor's degree in chemistry. She moved to Duke University for her graduate studies, and spent two years trying to prove to the department that she would be able to complete a PhD. She eventually earned a master's degree in the department of chemistry and began her doctoral research with Richard Polniaszek. Six months after starting, Polniaszek left the university, leaving Byrant-Friedrich to find a new project. [1] In 1993, after several weeks of German lessons, Byrant-Friedrich moved to Heidelberg University for her doctoral research. She worked on organic chemistry under the supervision of Richard Neidlein and completed her PhD in 1997. [2] Her doctoral research involved the synthesis of complex aromatic compounds.
In 1997 Byrant-Friedrich joined the research laboratory of Bernd Giese at the University of Basel as a postdoctoral fellow. [1] Here, she became interested in the use of organic chemistry as a means to study biological mechanisms. [1] After spending two years in Switzerland, Byrant-Friedrich moved back to the United States. Shortly after returning, Bryant-Friedrich worked at Wayne State University, but when it became obvious that she would not be awarded a tenure-track position, she looked for other options.
Byrant-Friedrich joined Oakland University as an assistant professor in 2000. She was awarded a National Science Foundation CAREER Award in 2003, which allowed her to study the chemical processes that damage DNA and RNA. [3] She moved to the University of Toledo in 2007.
Bryant-Friedrich was elected to serve as a 2022 chair in the American Chemical Society Medical Division of Medicinal Chemistry (ACS MEDI). [4]
She studies the mechanisms by which small molecules interact with nucleic acid. Her research involves the synthesis of modified nucleosides and nucleotides, monitoring the intercalation of small aromatic systems into DNA via the design of novel chromophores and the creation of probes that contain nucleic acids to study events that occur around DNA. She has studied the protection of small nuclear RNA (snRNAs) from oxidative damage, which typically damages cells. [5] As snRNA is essential for the function of spliceosome, this type of damage can impact the structure and function of the spliceosome.
In 2016 it was announced that Byrant-Friedrich would become the dean of the college of graduate studies at the University of Toledo. [6] She holds various honorary positions, including commissioner for the Lake Erie Commission. She has simultaneously held leadership roles in the American Chemical Society Division of Toxicology and Medicinal Chemistry. [7] Alongside her research and administrative duties, Byrant-Friedrich works to support women and minority scientists. [8]
In 2020, Bryant-Friedrich was named the dean of the graduate school at Wayne State University. [9] Additionally, she was hired to teach at Wayne State's College of Pharmacy and Health Sciences, where she would run a laboratory to conduct research. [10]
Her awards and honours include:
Byrant-Friedrich was profiled in African American Women Chemists in the Modern Era. Oxford University Press. 8 August 2018. ISBN 9780190615185. She is married to Klaus Freidrich with whom she has two children. [7]
Jacqueline K. Barton, is an American chemist. She worked as a professor of chemistry at Hunter College (1980–82), and at Columbia University (1983–89) before joining the California Institute of Technology. In 1997 she became the Arthur and Marian Hanisch Memorial Professor of Chemistry and from 2009 to 2019, the Norman Davidson Leadership Chair of the Division of Chemistry and Chemical Engineering at Caltech. She currently is the John G. Kirkwood and Arthur A. Noyes Professor of Chemistry, Emerita.
Dale Lester Boger is an American medicinal and organic chemist and former chair of the Department of Chemistry at The Scripps Research Institute in La Jolla, CA.
Lara K. Mahal is an American chemist who is the Canada Excellence Research Chair in Glycomics at the University of Alberta in Edmonton, Alberta, Canada. She is also a Professor of Chemistry at the University of Alberta. She is notable both for her pioneering work establishing lectin microarrays as a new technology for glycomics, her work on miRNA regulation of glycosylation and her graduate work with Carolyn R. Bertozzi on unnatural carbohydrate incorporation. Work in her laboratory focuses on understanding the role of carbohydrates in human health using systems- and chemical biology-based approaches
Angela K. Wilson is an American scientist and former (2022) President of the American Chemical Society. She currently serves as the John A. Hannah Distinguished Professor of Chemistry, associate dean for strategic initiatives in the College of Natural Sciences, and director of the MSU Center for Quantum Computing, Science, and Engineering (MSU-Q) at Michigan State University.
Paula Therese Hammond is an Institute Professor and the Vice Provost for Faculty at the Massachusetts Institute of Technology (MIT). She was the first woman and person of color appointed as head of the Chemical Engineering department. Her laboratory designs polymers and nanoparticles for drug delivery and energy-related applications including batteries and fuel cells.
Robert Vince is an American scientist known for his contributions to the research in the area of drug design. He is currently the director and professor at the Center for Drug Design at the Academic Health Center for the University of Minnesota.
Sandra Charlene Greer is an American physical chemist who has held important academic and administrative positions at both the University of Maryland, College Park and Mills College. Her area of study is the thermodynamics of fluids, especially polymer solutions and phase transitions. She has received awards for her scientific contributions, and for her advocacy for women in science and her work on ethics in science.
Cynthia J. Burrows is an American chemist, currently a distinguished professor in the department of chemistry at the University of Utah, where she is also the Thatcher Presidential Endowed Chair of Biological Chemistry. Burrows was the Senior Editor of the Journal of Organic Chemistry (2001-2013) and became Editor-in-Chief of Accounts of Chemical Research in 2014.,,
Sherry J. Yennello is an American nuclear chemist / nuclear physicist and an Elected Fellow of the American Association for the Advancement of Science. She is a Regents Professor and the holder of the Cyclotron Institute Bright Chair in Nuclear Science, who currently serves as the Director of the Cyclotron Institute at Texas A&M University. She is also a Fellow of the American Chemical Society and the American Physical Society. She has authored as well as co-authored more than 530 peer reviewed journal articles and has conducted many invited talks, presentations and seminars at several prestigious academic conferences and scholarly lectures.
Nina Matheny Roscher (1938—2001) was an American chemist and advocate for women and minorities in science. She also researched the history of women in chemistry, publishing the book Women Chemists (1995). She served as professor and chair of the chemistry department at American University in Washington, D.C. She received the ACS Award for Encouraging Women into Careers in the Chemical Sciences (1996) and the Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring (1998).
Marcey Lynn Waters is the Glen H. Elder Jr., Distinguished Professor of Chemistry at the University of North Carolina, Chapel Hill (UNC-CH). She is an organic chemist whose research is at the interface of chemical biology and supramolecular chemistry. Waters has received multiple awards for research, teaching, and advocating for women in science. She served as president of the American Peptide Society (APS) from 2017 to 2019.
Christine "Christy" Chow is a professor of chemistry and former associate dean of the College of Liberal Arts and Sciences at Wayne State University. She works on modified RNAs, RNA-ligand interactions and RNA therapeutics. She is a Fellow of the American Chemical Society (ACS).
Steven D'Wayne Townsend is a professor of organic chemistry at Vanderbilt University. He investigates the chemistry of human breast milk. In 2019 Townsend was selected as one of Chemical & Engineering News Talented 12.
Nina Irene McClelland was an American chemist. She was dean emeritus and professor of chemistry at the University of Toledo.
So-Jung Park 박소정(朴昭靜) is a professor of chemistry at Ewha Womans University, Republic of Korea. Her research considers the self-assembly of nanoparticles and functional molecules for biomedical and optoelectronic devices. She serves as Associate Editor of ACS Applied Materials & Interfaces and Nanoscale.
Kristi Lynn Kiick is the Blue and Gold Distinguished Professor of Materials Science and Engineering at the University of Delaware. She studies polymers, biomaterials and hydrogels for drug delivery and regenerative medicine. She is a Fellow of the American Chemical Society, the American Institute for Medical and Biological Engineering, and of the National Academy of Inventors. She served for nearly eight years as the deputy dean of the college of engineering at the University of Delaware.
Stephanie Lee Brock is an American chemist who is professor of inorganic chemistry at Wayne State University. Her research considers transition metal pnictides and chalcogenide nanomaterials. She is a Fellow of the American Association for the Advancement of Science and the American Chemical Society.
Loren Dean Williams is a biophysicist, biochemist, astrobiologist, and professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology in Atlanta, Georgia. His research seeks to understand the structural basis for macromolecular reactions, from the role of nucleic acids as targets of chemotherapeutics to the ancestral biochemistry of the ribosome during the origin of life.
Markita del Carpio Landry is a Bolivian-American chemist who is an associate professor in the department of chemical engineering at the University of California, Berkeley. Her research considers nanomaterials for brain imaging and the development of sustainable crops. She was a recipient of the 2022 Vilcek prize for creative promise. del Carpio Landry's work has been featured on NPR, popular mechanics, the San Francisco Chronicle, and C&E News.
Amanda E. Hargrove is a chemist and professor at Duke University. Hargrove is also the editor-in-chief of Medicinal Research Reviews, and a member of the Scientific Advisory Board of Arrakis Therapeutics. At Duke University, Hargrove directs an interdisciplinary research program in chemical biology that focuses on harnessing the specific interactions between small molecules and RNA, and using those RNA-small molecule interactions to probe the structure, and function of RNA. The long-term goal of the group's research is to identify specific molecule-RNA interactions that may have therapeutic potential in the treatment of viral infection and human disease. She has received numerous awards for her scientific research, teaching, and service in support of diversity, equity, and inclusion.